Earnings Summary

Inspire Medical Systems Inc’s revenue jumped 72.56% since last year same period to $91.39Mn in the Q2 2022. On a quarterly growth basis, Inspire Medical Systems Inc has generated 31.71% jump in its revenue since last 3-months.

Inspire Medical Systems Inc’s net profit fell -10.71% since last year same period to $-14.49Mn in the Q2 2022. On a quarterly growth basis, Inspire Medical Systems Inc has generated 13.2% jump in its net profits since last 3-months.

Inspire Medical Systems Inc’s net profit margin jumped 35.84% since last year same period to -15.86% in the Q2 2022. On a quarterly growth basis, Inspire Medical Systems Inc has generated 34.1% jump in its net profit margins since last 3-months.

Inspire Medical Systems Inc’s earning per share (EPS) estimates for the current quarter stand at -0.74 - a -19.35% fall from last quarter’s estimates.

Inspire Medical Systems Inc’s earning per share (EPS) estimates for the current year stand at -0.74.

Inspire Medical Systems Inc’s earning per share (EPS) fell -10.42% since last year same period to -0.53 in the Q2 2022. This indicates that the Inspire Medical Systems Inc has generated -10.42% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Inspire Medical Systems Inc’s return on assets (ROA) stands at -0.09.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Inspire Medical Systems Inc’s return on equity (ROE) stands at -0.2.

Inspire Medical Systems Inc declared 0 dividend per share during the earnings announcement for Q2 2022.